Literature DB >> 11834375

T cell responses to Chlamydia trachomatis.

Wendy P Loomis1, Michael N Starnbach.   

Abstract

Chlamydia trachomatis is the most common cause of bacterial sexually transmitted disease in the United States, as well as the leading cause of preventable blindness worldwide. Immunity to C. trachomatis requires a variety of cell types, each employing an array of effector functions. Recent work has demonstrated that both CD4+ and CD8+ T lymphocytes play a major role in protective immunity to C. trachomatis, predominantly through their secretion of interferon-gamma. This review describes the generation of acquired immunity to C. trachomatis and focuses on how T cells contribute to both protection and immunopathology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834375     DOI: 10.1016/s1369-5274(02)00291-6

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  39 in total

1.  Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation.

Authors:  Robert J Belland; David E Nelson; Dezso Virok; Deborah D Crane; Daniel Hogan; Daniel Sturdevant; Wandy L Beatty; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

2.  Induction of immune memory by a multisubunit chlamydial vaccine.

Authors:  F O Eko; E Ekong; Q He; C M Black; J U Igietseme
Journal:  Vaccine       Date:  2010-12-22       Impact factor: 3.641

3.  Lymphogranuloma venereum proctocolitis: mucosal T cell immunity of the rectum associated with chlamydial clearance and clinical recovery.

Authors:  C van Nieuwkoop; J Gooskens; V T H B M Smit; E C J Claas; R A van Hogezand; A C M Kroes; F P Kroon
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

4.  Effect of IL12A and IL12B polymorphisms on the risk of Chlamydia trachomatis-induced tubal factor infertility and disease severity.

Authors:  H Ohman; R Bailey; A Natividad; J Ragoussis; L-L Johnson; A Tiitinen; M Halttunen; J Paavonen; H-M Surcel
Journal:  Hum Reprod       Date:  2012-05-11       Impact factor: 6.918

5.  Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.

Authors:  C Wang; J Tang; P A Crowley-Nowick; C M Wilson; R A Kaslow; W M Geisler
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

6.  CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection.

Authors:  J M Moore-Connors; H S Kim; J S Marshall; A W Stadnyk; S A Halperin; J Wang
Journal:  Mucosal Immunol       Date:  2014-06-18       Impact factor: 7.313

7.  Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses.

Authors:  B S Reddy; S Rastogi; B Das; S Salhan; S Verma; A Mittal
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Endogenous processing and presentation of T-cell epitopes from Chlamydia trachomatis with relevance in HLA-B27-associated reactive arthritis.

Authors:  Juan J Cragnolini; Noel García-Medel; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2009-05-13       Impact factor: 5.911

9.  A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Authors:  Eno E Ekong; Daniel N Okenu; Jayanti Mania-Pramanik; Qing He; Joseph U Igietseme; Godwin A Ananaba; Deborah Lyn; Carolyn Black; Francis O Eko
Journal:  FEMS Immunol Med Microbiol       Date:  2008-11-18

Review 10.  The global burden of trachoma: a review.

Authors:  Matthew J Burton; David C W Mabey
Journal:  PLoS Negl Trop Dis       Date:  2009-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.